


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.51%
-1.41%
+1.86%
+2.64%
-1.18%
RVTY
Revvity
$109.72
Strengths

Earnings are forecast to grow

Expands stock buyback program

Upgraded on attractively valued

Trading below its fair value
RVTY Price Performance
$100.49 (+9.18%)
$92.12 (+19.11%)
$91.71 (+19.64%)
$126.84 (-13.50%)
RVTY has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

RVTY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Reported a weak earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
RVTY Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RVTY Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
RVTY
Revvity
109.72
+5.56%
CLF
Cleveland-Cliffs Inc
13.28
+2.91%
SLB
Schlumberger
45.85
+1.54%
IRWD
Ironwood Pharma
4.60
+1.79%
ALLY
Ally Financial Inc.
43.73
-1.40%
What is RVTY current stock price?
What are RVTY stock strengths?
What is RVTY Risk Level?
What is RVTY market cap and volume?
What is RVTY current Stock IQ?
Should I buy RVTY stock right now?
Is RVTY a Strong Buy right now?
What does a 'Strong Buy' rating mean for RVTY?
What does a 'Strong Sell' rating mean for RVTY?
What factors influence RVTY's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-3.51%
-1.41%
+1.86%
+2.64%
-1.18%
RVTY
Revvity
Current Price
$109.72
RVTY Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Expands stock buyback program

Upgraded on attractively valued

Trading below its fair value
Recently Viewed
RVTY
Revvity
109.72
+5.56%
CLF
Cleveland-Cliffs Inc
13.28
+2.91%
SLB
Schlumberger
45.85
+1.54%
IRWD
Ironwood Pharma
4.60
+1.79%
ALLY
Ally Financial Inc.
43.73
-1.40%

RVTY Price Performance
$100.49 (+9.18%)
$92.12 (+19.11%)
$91.71 (+19.64%)
$126.84 (-13.50%)
RVTY Analysts Opinion
RVTY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Reported a weak earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
RVTY Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RVTY Street Sentiment is extremely bullish and have negative views on the near-term outlook
RVTY has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
RVTY Latest Analysis
Revvity trades higher on earnings guidance above consensus.
Today
S&P 500 Movers: V RVTY. In early trading on Tuesday shares of Revvity topped the list of the days best performing components of the S&.P 500 index trading up 9.7%. Year to date Revvity registers a 17.8% gain.And the worst performing S&.P 500 component thus far on the day is Visa trading d
Today
RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models. Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica aiming to unlock secure federated drug discovery at scale.
Mon Jan 12, 2026
Revvity Lilly Partner To Expand Access To AI Drug Discovery Models . (RTTNews) - Revvity Inc. (RVTY) on Friday announced a collaboration with Eli Lilly and Company (LLY) to make Lilly TuneLab Lillys AI-driven predictive modeling platform available through the Revvity Signals platform expanding access to advanced AI tools for drug discovery.
Fri Jan 9, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
RVTY Stock trends
RVTY Stock performance
RVTY Stock analysis
RVTY investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.